Your browser doesn't support javascript.
loading
Design, Synthesis, and Biological Evaluation of Novel Quinazoline Clubbed Thiazoline Derivatives.
Ali, Zulphikar; Akhtar, Md J; Siddiqui, Anees A; Khan, Ahsan A; Haider, Md R; Yar, Mohammad S.
Afiliação
  • Ali Z; Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Jamia Hamdard (Hamdard University), Hamdard Nagar, New Delhi, India.
  • Akhtar MJ; Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Jamia Hamdard (Hamdard University), Hamdard Nagar, New Delhi, India.
  • Siddiqui AA; Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Jamia Hamdard (Hamdard University), Hamdard Nagar, New Delhi, India.
  • Khan AA; Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Jamia Hamdard (Hamdard University), Hamdard Nagar, New Delhi, India.
  • Haider MR; Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Jamia Hamdard (Hamdard University), Hamdard Nagar, New Delhi, India.
  • Yar MS; Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Jamia Hamdard (Hamdard University), Hamdard Nagar, New Delhi, India.
Arch Pharm (Weinheim) ; 350(2)2017 Feb.
Article em En | MEDLINE | ID: mdl-28093794
A novel series of quinazoline clubbed thiazoline derivatives was rationally designed and synthesized. The newly synthesized compounds were evaluated for in vitro dipeptidyl peptidase IV (DPP-4) inhibitory activity. Compounds that showed good to moderate activity were compared using linagliptin as standard. Compound 4x (IC50 = 1.12 nM) exhibited the most promising results. The special chemical feature of compound 4x also imparts good inhibition selectivity for DPP-4 over DPP-8/9. Moreover, docking of compound 4x into the active site of DPP-4 illustrates its possible binding interactions.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinazolinas / Desenho de Fármacos / Dipeptidil Peptidases e Tripeptidil Peptidases / Inibidores da Dipeptidil Peptidase IV Limite: Animals Idioma: En Revista: Arch Pharm (Weinheim) Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Índia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinazolinas / Desenho de Fármacos / Dipeptidil Peptidases e Tripeptidil Peptidases / Inibidores da Dipeptidil Peptidase IV Limite: Animals Idioma: En Revista: Arch Pharm (Weinheim) Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Índia